Mid-afternoon and the AIM All Share is struggling to make progress, lagging the main board. Budget uncertainty is likely weighing – again – and the junior index is trading down just over two points at 2.30pm, at 770.33.
- Genedrive +46%
- Idox +25%
- Diales +15%
- Future Metals -21%
- Team -17%
Genedrive LON:GDR was the biggest gainer on the day, adding 46% by copy time as the market responded to news that the company had signed an MoU with Saudi Arabia for the sale of kit allowing better diagnosis to be made in neonatal intensive care units.
- AIM Market Roundup: Proteome Sciences, TAP Global, Various Eateries
- AIM Market Roundup: Future Metals, Renalytix, Nativo Resources
Idox LON:IDOX was in second place added 25% after a significant shareholder initiated a take-private move which garnered the support of management too. The gain accounts for the vast majority of the bid premium.
Diales [LON:DIAL] gets the notable mention, up 15% at copy time. That seems to have been fuelled by a year end trading update. Despite the broad economic headwinds, the company remains on track to deliver against expectations and notes that momentum is being maintained as FY26 gets underway.
Future Metals [LON:FME] traded 21% lower on the day. The shares have been slipping since the announcement three weeks ago that management intended to delist the stock, although notably the losses here haven’t been quite as dramatic as is typically seen.
- AIM Market Roundup: Tower Resources, Bezant, Reabold
- AIM Market Roundup: Future Metals, Renalytix, Nativo Resources
Team LON:TEAM was 17% down at 2.30pm although again there’s nothing much to report here. Trading has been thin with the downside being concentrated. The stock often sees extended periods of no trade.
